BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37899193)

  • 1. [Prophylaxis and treatment of hematological malignancy-associated thrombosis].
    Ikezoe T
    Rinsho Ketsueki; 2023; 64(9):1137-1143. PubMed ID: 37899193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism and risk stratification in hematological malignancies.
    Sanfilippo KM
    Thromb Res; 2022 May; 213 Suppl 1():S16-S21. PubMed ID: 36210555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Thrombohemorrhagic Syndromes (THS) in hematologic malignancies.
    Falanga A; Rickles FR
    Hematology Am Soc Hematol Educ Program; 2007; ():165-71. PubMed ID: 18024625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism in the hematologic malignancies.
    Falanga A; Marchetti M; Russo L
    Curr Opin Oncol; 2012 Nov; 24(6):702-10. PubMed ID: 23014188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma.
    Wun T; White RH
    Thromb Res; 2010 Apr; 125 Suppl 2():S96-102. PubMed ID: 20434017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-associated thrombosis in hematologic malignancies.
    Fukatsu M; Ikezoe T
    Int J Hematol; 2024 May; 119(5):516-525. PubMed ID: 38270784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of thromboembolism in hematologic malignancies.
    Chong BH; Lee SH
    Semin Thromb Hemost; 2007 Jun; 33(4):435-48. PubMed ID: 17525901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of direct oral anticoagulants for venous thromboembolism and stroke prophylaxis in patients with hematologic malignancies.
    Kim S; Namba J; Goodman AM; Nguyen T; Saunders IM
    J Oncol Pharm Pract; 2020 Mar; 26(2):351-360. PubMed ID: 31142232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances in the target therapy of hematological malignancies].
    Niu T; Liu T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 45(4):642-6. PubMed ID: 25286692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism incidence in hematologic malignancies.
    Kekre N; Connors JM
    Blood Rev; 2019 Jan; 33():24-32. PubMed ID: 30262170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of enoxaparin treatment in venous thromboembolic disease during acute leukemia.
    Imberti D; Vallisa D; Anselmi E; Moroni CF; Bertè R; Lazzaro A; Bernuzzi P; Arcari AL; Cavanna L
    Tumori; 2004; 90(4):390-3. PubMed ID: 15510981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary Manifestations of Lymphoma and Leukemia.
    Bashoura L; Eapen GA; Faiz SA
    Clin Chest Med; 2017 Jun; 38(2):187-200. PubMed ID: 28477632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism in the hematologic malignancies.
    Falanga A; Marchetti M
    J Clin Oncol; 2009 Oct; 27(29):4848-57. PubMed ID: 19752334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravascular clotting activation and bleeding in patients with hematologic malignancies.
    Tallman MS; Kwaan HC
    Rev Clin Exp Hematol; 2004 Jun; 8(1):E1. PubMed ID: 16029967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism prophylaxis in patients with multiple myeloma: where are we and where are we going?
    Lapietra G; Serrao A; Fazio F; Petrucci MT; Chistolini A
    J Thromb Thrombolysis; 2021 Aug; 52(2):584-589. PubMed ID: 33417149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
    Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments and persisting challenges in the prevention and treatment of venous thromboembolism in patients with hematological malignancies.
    Sorigue M; Cañamero E; Siguenza P; Nomdedeu M; López-Núñez JJ
    Leuk Lymphoma; 2020 Jun; 61(6):1277-1291. PubMed ID: 31960713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral Venous Thrombosis in Hematological Malignancy: Balancing the Risks.
    Pinto MJ; Medeiros PB; Príncipe F; Carvalho M
    J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104683. PubMed ID: 32059925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolic complications in pediatric hematologic malignancies.
    Athale UH; Chan AK
    Semin Thromb Hemost; 2007 Jun; 33(4):416-26. PubMed ID: 17525899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombosis in hematological malignancies: mechanisms and implications.
    Horowitz NA; Brenner B
    Thromb Res; 2020 Jul; 191 Suppl 1():S58-S62. PubMed ID: 32736780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.